Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Melinta Therapeutics Inc (MLNT)

Melinta Therapeutics Inc (MLNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 6,050
  • Shares Outstanding, K 13,751
  • Annual Sales, $ 96,430 K
  • Annual Income, $ -157,190 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 4.16
  • Price/Sales 0.07
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -9.47
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 11/13/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -1.93
  • Growth Rate Est. (year over year) +51,861.66%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3100 +41.94%
on 01/13/20
1.6900 -73.96%
on 12/16/19
-1.1200 (-71.79%)
since 12/13/19
3-Month
0.3100 +41.94%
on 01/13/20
5.6200 -92.17%
on 10/23/19
-3.3700 (-88.45%)
since 10/11/19
52-Week
0.3100 +41.94%
on 01/13/20
10.1000 -95.64%
on 02/07/19
-4.8600 (-91.70%)
since 01/11/19

Business Summary

Melinta Therapeutics, Inc. develops and commercializes novel antibiotics designed to provide new and better therapeutic solutions. Melinta's lead product is Baxdela, an antibiotic approved by the US FDA for use in the treatment of acute bacterial skin and skin structure infections (ABSSSI). Melinta also...

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 0.5533
1st Resistance Point 0.4967
Last Price 0.4400
1st Support Level 0.3467
2nd Support Level 0.2533
3rd Support Level N/A

See More

52-Week High 10.1000
Fibonacci 61.8% 6.3602
Fibonacci 50% 5.2050
Fibonacci 38.2% 4.0498
Last Price 0.4400
52-Week Low 0.3100

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar